Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

 

Healixia provides training and networking opportunities for each of the 4 domains on the right.
Also discover the Healixia cross-domains events.

 
 

Healixia events

  1. link Linked'In.jpg
    01 February '22

    Healixia New Year's Event WILL NOT TAKE PLACE

    Due to COVID, our planned New Year's Event will not take place.

  2. j-kelly-brito-PeUJyoylfe4-unsplash.jpg
    22 February '22

    Webinar - Innovation in Healthcare: Current and future trends

    There are 342 places available.

    Online meeting

    In this webinar, Giovanni Briganti will introduce the field of AI in healthcare, starting from a scientific standpoint to clinical applications, as well as the promise and challenges that it entails for the Belgian Landscape.

  3. nani-chavez-EKHB_4kEYzw-unsplash.jpg
    24 March '22

    Healixia Annual Conference: Current and future trends in patient centric solutions for healthcare

    Diegem

    Healixia Annual Conference 2022: Current and future trends in patient centric solutions for healthcare.

Show all meetings

News

  1. January 18, 2022

    Give your opinion on a genetically modified medicine for the treatment of Duchenne muscular dystrophy

    The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial of the genetically modified medicine SRP-9001 for the treatment of Duchenne muscular dystrophy. The public consultation runs from 17 January 2022 to 16 February 2022.

    Source: FAMHP

    Read more

  2. January 13, 2022

    Give your opinion on a genetically modified medicine for the treatment of various types of advanced cancer

    The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial testing the genetically modified oncolytic virus VSV-GP (BI 1831169), for the treatment of patients with various types of advanced cancer (solid tumours). The public consultation runs from 11 January 2022 to 10 February 2022.

    Source: FAMHP

    Read more

  3. January 11, 2022

    COVID-19 webinar update from Brazil: Critical Retrospective of the COVID-19 Pandemic in Brazil (2020-2021)

    After the first webinar of its kind in December 2020, SBMF, the IFAPP member association from Brazil will provide a “Critical Retrospective of the COVID-19 Pandemic in Brazil” on 20 January 2022, 12:00-13:30 CET.

    Read more

We thank our partners for their support. Click on the logos for more information:
 
digidyco_clinical esolutions_gr_web2.png QbD_logo_RGB_300dpi logo Hebias web.png Modis 440x320 nieuwsbrief.jpg
jsn_logo_jj_vert_color_rgb.jpg 20201210 AxTalis Logo MAx MA.jpg SCIENCETALENTS_LOGO_RGB_POS.png Brookwood Global-website.png